SPINEWAY to participate in the SFCR Annual Congress

France’s premier spine surgery event

A leading event for spine surgery in France, the SFCR Annual Congress brings together over 400 French-speaking healthcare professionals each year to discuss the latest scientific and technical advances in the specialty.
Topics covered during this year’s Congress will include spinal deformities, lumbar adjacent segment disease, endoscopy, and the cervical spine, as well as dedicated pediatric sessions.

The SFCR brings together all major players in the field, including neurosurgeons, orthopedic surgeons, senior and junior physicians, clinical fellows, rehabilitation specialists, and biomechanical engineers. Around 40 exhibitors will also showcase their latest innovations aimed at improving the treatment of spine disorders.

The 2026 edition will mark SPINEWAY’s twelfth participation in the Congress, reaffirming its long-standing commitment to the French scientific and medical community as a Bronze Sponsor, a status the Group has held among the event’s principal partners since 2022.
During the congress, SPINEWAY’s teams will present their full range of spine surgery solutions at their exhibition booth, including the VEOS/KAPHORN platform for posterior spinal fusion, ESP cervical and lumbar disc prostheses for total disc replacement, and ACIFBOX cages for anterior cervical fusion. Demonstrations will be conducted throughout the event, providing visitors with the opportunity to discover the technical features and clinical benefits of these devices.

The Congress represents a valuable opportunity for SPINEWAY to strengthen its dialog with French healthcare professionals, engage directly with users of its solutions, and gather feedback to support the development and enhancement of future product lines. It will also enable the Group to contribute to the scientific and technical exchanges that are shaping the future of spine surgery. 

Next event:

July 30, 2026 – H1 2026 revenue and results

About Spineway

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 60 independent distributors and more than 70% of its revenue comes from exports.

Spineway is eligible for the PEA-PME (equity savings plans for SMEs)

Listing venue: Euronext Growth Paris
ISIN: FR001400N2P2
Ticker: ALSPW

Find out all about Spineway at www.spineway.com

Contacts :

Spineway
Shareholder-services line
Available Tuesday through Thursday (10 a.m.-12 midday) 
08 06 70 60 60

Aelium
Investor relations
spineway@aelium.fr

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.